New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO ® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)
TITUSVILLE, NJ, March 5, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from a new prespecified analysis from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefits of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) over standard of care (aspirin alone), demonstrating consistent benefit at 30 days, 90 days and up to three years following LER in patients with PAD. Lower extremity revascularization, also called peripheral revascularization, is a procedure that restores blood flow in blocked arteries or veins. This analysis of ...
Source: Johnson and Johnson - March 5, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Fewer Surprise Bills: Most U.S. Hospitals Now Transparent on Prices
MONDAY, Feb. 20, 2023 -- Shopping for cataract surgery, a heart valve replacement or a colonoscopy?
You ’re better able these days to compare what one hospital charges against the prices at another, according to a new report from the U.S. Centers... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 20, 2023 Category: General Medicine Source Type: news
Should Medtronic's Recent Colibri Patent Controversy Concern You?
Why is Russia reopening dormant copper mines? (From Investing Trends) In early February 2023, Medtronic PLC (NYSE: MDT) was found guilty of patent infringement regarding Colibri Heart Valve LLC transcatheter aortic valve replacement system (TAVR). While this is certainly troubling for one of the…#medtronicplc #medtronic #mdt #dublin #ireland #colibri #corevalve #tavr #medtronicsevolut #colibris (Source: Reuters: Health)
Source: Reuters: Health - February 13, 2023 Category: Consumer Health News Source Type: news
New keyhole surgery plan to slash hospital recovery time for patients with heart valve complaints
The operation is designed to cure a condition called aortic valve stenosis, which happens when a crucial valve in the heart narrows and reduces blood flow around the body. (Source: the Mail online | Health)
Source: the Mail online | Health - February 11, 2023 Category: Consumer Health News Source Type: news
Medtronic hit with $106M verdict in patent fight with Colibri Heart Valve
A federal jury in California decided that a unit of Medtronic (NYSE: MDT) must pay $106.5 million in a patent-infringement lawsuit filed by a rival maker of heart valve devices.
Reuters has a report on the verdict, which found in favor of Louisville, Colorado-based Colibri Heart Valve. Colibri claimed that Medtronic CoreValve Evolut devices violate one of its own patents. Colibri's patent isn't for the device itself, but rather for the method of deploying self-expanding artificial heart valves … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 10, 2023 Category: Pharmaceuticals Authors: Mark Reilly Source Type: news
Heart valve repair company Cardiac Dimensions raises $35M
The Kirkland-based company is growing its 55-person team and working to get its device — already available in Europe and Australia — approved for use in the U.S. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 9, 2023 Category: Pharmaceuticals Authors: Rick Morgan Source Type: news
Black Patients More Likely to Get Riskier Heart Surgeries
WEDNESDAY, Dec. 28, 2022 -- Insured Black patients are less likely to undergo minimally invasive heart valve replacement or repairs -- relatively safe procedures -- than their white counterparts, new research shows.
Black patients who need a mitral... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 28, 2022 Category: General Medicine Source Type: news
Real-World Study Confirms Benefit of XARELTO ® (rivaroxaban) for Secondary Prevention of Venous Thromboembolism in Cancer Patients
TITUSVILLE, NJ, December 9, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that the oral Factor Xa inhibitor XARELTO® (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a broad cohort of patients with various cancer types. Patients with CAT are at a higher risk of venous thromboembolism (VTE), which is the second-leading cause of death in people with cancer.1Data from the Observational Study in Cancer-A...
Source: Johnson and Johnson - December 9, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
AHA News: A Heart Attack During Pregnancy, Then Heart Valve Surgery
WEDNESDAY, Dec. 7, 2022 (American Heart Association News) -- As she walked up to her fourth-floor apartment, Marisa MacDonnell figured something was different with this pregnancy, her second.
She felt winded. She had to take deeper breaths. And... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2022 Category: General Medicine Source Type: news
Atrium Health extends a cardiac lifeline to residents of Belize
More than 1 million cardiac catheterization procedures are performed each year in the U.S. to diagnose and treat common heart conditions including heart vessel blockages, irregular heartbeats or heart valve problems. It is a procedure often taken for granted.
But imagine none of the medical facilities in the country where you live offered that procedure? That was the case in Belize, a Caribbean country on the northeastern coast of Central America with about 400,000 residents. Until 10 years ago, … (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - December 1, 2022 Category: Health Management Authors: Atrium Health Source Type: news
Atlanta startup Nyra Medical raising $20M for device that repairs leaking heart valves
Nyra Medical Inc. is developing technology that fixes leaking heart valves by placing an implant into the heart. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 28, 2022 Category: Health Management Authors: Zach Armstrong Source Type: news
Indian medical devices more cost-effective: Union Minister
The Minister of State (independent charge) for Science and Technology was addressing the faculty and students after inaugurating the combined devices block at the Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST) here. Technologies like the artificial heart valve, hydrocephalus shunt, oxygenator and drug-eluting intra-uterine device developed by the SCTIMST are being manufactured in countries like the USA, Japan, Brazil, and China, he said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 15, 2022 Category: Pharmaceuticals Source Type: news
Some Women's Bioprosthetic Heart Valves Don't Hold Up to Pregnancy
(MedPage Today) -- Certain women with bioprosthetic heart valves were more likely to have devices deteriorate by the time they got pregnant, opening the door to increased risk of maternal and fetal events, a retrospective study found.
At the first... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 14, 2022 Category: Cardiology Source Type: news
PROACT Xa Trial of Apixaban With On-X Heart Valve Stopped PROACT Xa Trial of Apixaban With On-X Heart Valve Stopped
The DSMB cited a lack of evidence supporting noninferiority of apixaban over warfarin for valve thrombosis and thromboembolism.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 29, 2022 Category: Intensive Care Tags: Cardiology News Source Type: news
World-first partial heart transplant with 'living tissue' saves baby boy born with fused arteries
Owen Monroe, from North Carolina, was born with his two main arteries fused together. Doctors used living tissue to seprate them and replace heart valves, which will grow with the infant. (Source: the Mail online | Health)
Source: the Mail online | Health - September 12, 2022 Category: Consumer Health News Source Type: news
